T Cell News and Research

Latest T Cell News and Research

Designer molecules that combine metals such as copper with natural organic materials could treat diseases in the body

That's the finding of chemists at Ohio State University, who have successfully tested such molecules against portions of HIV and Hepatitis C virus RNA in the laboratory. They've also created molecules that act like ACE, or angiotensin-converting enzyme, inhibitors - drugs that are used to lower blood pressure.

30 Aug 2005

Step towards understanding cell mutations that cause a variety of human diseases

A step towards understanding cell mutations that cause a variety of human diseases, particularly in children - including that which brings about premature aging and early death - has been taken by researchers at the Hebrew University of Jerusalem Silberman Institute of Life Sciences and the John Hopkins University School of Medicine.

30 Aug 2005

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Chemotherapy is standard treatment for patients with advanced non-small cell lung cancer, although benefits are modest and toxicity substantial. Massimo Di Maio and colleagues hypothesised that neutropenia, a haematological toxicity, could be a predictor of drug activity and treatment efficacy.

30 Aug 2005

New treatment can zap cancer cells and avoid healthy tissue

Australian researchers say they have developed a cancer treatment which can identify and kill individual cancer cells.

30 Aug 2005

Anti-cancer antibodies produced in chickens

A team of researchers have produced the first fully functional, human sequence monoclonal antibodies (mAbs) in chickens.

29 Aug 2005

Blocking Hutchinson-Gilford progeria syndrome (HGPS) with anticancer drugs

A class of anticancer drugs currently being evaluated in phase 3 clinical trials may also be an effective treatment for Hutchinson-Gilford progeria syndrome (HGPS), a fatal genetic disorder that causes premature aging.

29 Aug 2005

Three-dimensional molecular structure of a promising malaria-vaccine component

An international team of scientists that includes a researcher from the U.S. Department of Energy's Brookhaven National Laboratory has determined the three-dimensional molecular structure of a promising malaria-vaccine component.

29 Aug 2005

Drugs known as farnesyltransferase inhibitors (FTIs) may hold promise for premature aging disorder

In a surprising development, a research team led by the National Human Genome Research Institute (NHGRI), has found that a class of experimental anti-cancer drugs also shows promise in laboratory studies for treating a fatal genetic disorder that causes premature aging.

29 Aug 2005

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.

29 Aug 2005

Anthrax test receives FDA approval

A method for identifying Bacillus anthracis, the causative agent of anthrax, has been cleared for diagnostic use by the U.S. Food and Drug Administration (FDA).

29 Aug 2005

Discovery of multiple isoforms of the p53 tumor suppressor protein

25 years after the initial discovery of p53, Dr. David Lane and colleagues at the University of Dundee have discovered multiple isoforms of the p53 tumor suppressor protein.

29 Aug 2005

Early statin therapy may be essential for reducing mortality and other complications in heart attack victims

In the largest clinical study of its kind, UCLA researchers found that early treatment with a statin drug within 24 hours of having a heart attack reduced in-hospital mortality rates by over 50 percent.

29 Aug 2005

Unusual type of antibiotic shows promise in defeating deadly "superbugs"

An unusual type of antibiotic being developed by chemists at Notre Dame University shows promise in defeating deadly "superbugs" - highly drug-resistant staph bacteria that are an increasing source of hospital-based infections.

29 Aug 2005

Before hitting the beach, learn the signs of skin cancer

With summer coming to a close, the American Society for Therapeutic Radiology and Oncology has published a new brochure to help the public understand the signs and symptoms of skin cancer as well as learn the treatment options for the disease.

29 Aug 2005

High-dose anticancer chemotherapy and total body irradiation during childhood can damage developing teeth

Research published by the University of Helsinki, Finland, indicates that cytostatic and radiation therapies administered before stem cell transplantation often damage children's permanent teeth.

29 Aug 2005

New laboratory method for quickly detecting active anthrax proteins

A new laboratory method for quickly detecting active anthrax proteins within an infected blood sample at extremely low levels has been developed by researchers at the National Institute of Standards and Technology (NIST), the U.S. Army Medical Research Institute of Infectious Diseases and the National Cancer Institute.

29 Aug 2005

Molecular missing link between fasting and acute attacks of porphyria

A team of researchers has discovered a molecular missing link that helps explain why fasting brings on acute attacks of the genetic disease hepatic porphyria, according to a new report in the 26 August issue of the journal Cell.

29 Aug 2005

How germ cells decide whether to be sperm or eggs

Johns Hopkins biologists have determined how developing embryos tell their specialized "germ cells" whether to develop into a male's sperm or a female's eggs.

29 Aug 2005

Supermolecules strike blow to cancer cells

Chemistry and biology researchers at Virginia Tech have enhanced the abilities of the molecules they are creating to deliver killing blows to cancer cells. The man-made molecular complexes enter cancer cells and, when signaled, deliver killing medicine or cause the cell to change.

29 Aug 2005

Discovery may significantly advance the treatment of cancers and infectious diseases

Current treatments frequently achieve only limited results with these types of diseases, which affect hundreds of thousands of Canadians.

29 Aug 2005

T Cell News and Research

Latest T Cell News and Research

Designer molecules that combine metals such as copper with natural organic materials could treat diseases in the body

Step towards understanding cell mutations that cause a variety of human diseases

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

New treatment can zap cancer cells and avoid healthy tissue

Anti-cancer antibodies produced in chickens

Blocking Hutchinson-Gilford progeria syndrome (HGPS) with anticancer drugs

Three-dimensional molecular structure of a promising malaria-vaccine component

Drugs known as farnesyltransferase inhibitors (FTIs) may hold promise for premature aging disorder

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

Anthrax test receives FDA approval

Discovery of multiple isoforms of the p53 tumor suppressor protein

Early statin therapy may be essential for reducing mortality and other complications in heart attack victims

Unusual type of antibiotic shows promise in defeating deadly "superbugs"

Before hitting the beach, learn the signs of skin cancer

High-dose anticancer chemotherapy and total body irradiation during childhood can damage developing teeth

New laboratory method for quickly detecting active anthrax proteins

Molecular missing link between fasting and acute attacks of porphyria

How germ cells decide whether to be sperm or eggs

Supermolecules strike blow to cancer cells

Discovery may significantly advance the treatment of cancers and infectious diseases

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in